Venture_Socks_RZ_RGB_300dpi(2)_edited.pn

WINNERS

PiKe Pharma GmbH

2008

Health & Nutrition

PiKe Pharma GmbH develops small-molecule drugs for infectious diseases employing fragment-based synthesis of unique chemical libraries in combination with an innovative screening technology for the identification of novel protein-protein interaction inhibitors. The company was liquidated in 2015.

Venture_GreenLayer_v2_edited.png